Analysis of thyroid neoplasms in Brazilian women between 2013 and 2023: epidemiological study
DOI:
https://doi.org/10.59464/2359-4632.2025.3699Keywords:
Epidemiology, Thyroid Neoplasms, Women, Public Health Surveillance, Health Information SystemsAbstract
Objective: To analyze epidemiological data on thyroid neoplasms in women in Brazil between 2013 and 2023. Methods: This is an epidemiological, quantitative, and exploratory study carried out with information from SISCAN, SIM, and the ICD-10 Mortality Monitoring Panel, based on the following variables: region and Federative Unit (UF) of diagnosis, age group, therapeutic modality, treatment time, color/race, marital status, and place of death. Results: A total of 39,550 women were diagnosed between 2013 and 2023, with 2023 being the year with the highest number of cases (n = 8,312), with emphasis on the southeast region of the country (43.09%). This neoplasm was more prevalent in women aged between 50 and 54 years old (24%). During the period analyzed, the total number of women who died from the disease was equivalent to 15.09% (n = 5,971) of the number of female diagnoses of thyroid neoplasia. Conclusion: The number of diagnoses of thyroid neoplasia in women increased by 5,541% from 2013 to 2023. However, female mortality in each year remained close to the average value for the period (542 deaths/year). Therefore, primary prevention, through the adoption of healthy lifestyle habits, screening techniques and monitoring of the population at risk, associated with appropriate staging and classification, as well as periodic active surveillance of low-risk nodules, are the safest and most conservative strategies to ensure the quality of life of the population and reduce unfavorable outcomes.
References
Borges AKM, Ferreira JD, Koifman S, Koifman RJ. Thyroid cancer in Brazil: a descriptive study of cases held on hospital-based cancer registries, 2000-2016. Epidemiologia e Serviços de Saúde. 2020;29(4):1-11. DOI: http://dx.doi.org/10.5123/s1679-49742020000400012.
Instituto Nacional Do Câncer. Estimativa 2023: incidência de câncer no Brasil. Câncer de tireoide. 2022. Disponível em: https://www.inca.gov.br/sites/ufu.sti.inca.local/files/media/document/estimativa-2023.pdf.
Instituto Nacional De Câncer José Alencar Gomes Da Silva. Atlas on-line de mortalidade. INCA. 2020. Disponível em: https://mortalidade.inca.gov.br/MortalidadeWeb/pages/Modelo03/consultar.xhtml#panelResultado.
Ma CX, Ma XN, Li YD, Fu SB.. The role of primary cilia in thyroid cancer: from basic research to clinical applications. Frontiers in Endocrinology. 2021;12: e685228. DOI: https://doi.org/10.3389/fendo.2021.685228.
Rocha RM, Santos MCLFS, Musso C, Santos MHS, Almeida ML, Miguel GPS. Carcinoma bem diferenciado de tireoide: perfil epidemiológico, resultados cirúrgicos e resposta oncológica. Revista Do Colégio Brasileiro De Cirurgiões. 2018; 45(5): e1934. DOI: https://doi.org/10.1590/0100-6991e-20181934.
Zhang L, Zhou M, Gao X, Xie Y, Xiao J, Liu T, Zeng X. Estrogen-related genes for thyroid cancer prognosis, immune infiltration, staging, and drug sensitivity. BMC Cancer. 2023;23:1048. DOI: https://doi.org/10.1186/s12885-023-11556-0.
Chen LH, Xie T, Lei Q, Gu YR, Sun CZ. A review of complex hormone regulation in thyroid cancer: novel insights beyond the hypothalamus–pituitary–thyroid axis. Frontiers in endocrinology. 2024;15: e1419913.. DOI: http://dx.doi.org/10.3389/fendo.2024.1419913.
Liang Y, Li X, Wang F, Yan Z, Sang Y, Yuan Y, Qin Y, Zhang X, Ju M. Detection of thyroid nodule prevalence and associated risk factors in Southwest China: a study of 45,023 individuals undergoing physical examinations. Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy. 2023;16:1697–1707. DOI: https://doi.org/10.2147/DMSO.S412567.
Grani G, Sponziello M, Pecce V, Ramundo V, Durante C. Contemporary thyroid nodule evaluation and management. The Journal of Clinical Endocrinology and Metabolism. 2020;105(9):2869–2883. DOI: https://doi.org/10.1210/clinem/dgaa322.
Kant R, Davis A, Verma V. Thyroid nodules: advances in evaluation and management. American Family Physician. 2020;102(5):298–304. PMID: 32866364. Disponível em: https://pubmed.ncbi.nlm.nih.gov/32866364/.
Secretaria Municipal da Saúde de São Paulo. Protocolo SUS - Nódulos Tireoidianos. Departamento de Atenção Especializada. 2024; 1: 3-8.
Ministério da Saúde. Portaria Nº 7 De 03 De Janeiro De 2014. Brasília. 2014. Disponível em: https://www.gov.br/conitec/pt-br/midias/protocolos/pcdt_carcinomatireoide.pdf.
Ministério da Saúde. Mortalidade proporcional por grupos de causas em mulheres no Brasil em 2010 e 2019. Boletim Epidemiológico. 2022; 53: 1-12. Disponível em: https://www.gov.br/saude/pt-br/centrais-de-conteudo/publicacoes/boletins/epidemiologicos/edicoes/2021/boletim_epidemiologico_svs_29.pdf
Li M, Maso LD, Pizzato M, Vaccarella S. Evolving epidemiological patterns of thyroid cancer and estimates of overdiagnosis in 2013–17 in 63 countries worldwide: a population-based study. The Lancet Diabetes & Endocrinology. 2024; 12(11): 824-836. DOI: http://dx.doi.org/10.1016/S2213-8587(24)00223-7.
Nobre CB, Pareira MA, Meneses MVP, Mendonça MTA, Siqueira MMM, Sobreira SFN, Santos DB. Incidência e mortalidade por câncer de tireoide no brasil: um estudo epidemiológico. RevistaFT. 2024; 29(140). DOI: http://dx.doi.org/10.69849/revistaft/fa10202411101820.
Patel N, Bavikar R, Lad YP, Singh M, Dharwadkar A, Viswanathan V. A comparison of the WHO 2004 and WHO 2017 thyroid tumor classifications. Journal of Cancer Research and Therapeutics. 2023;20(1):311-314. DOI: http://dx.doi.org/10.4103/jcrt.jcrt_1797_22.
Chung R,Guan H, Ponchiardi C, Cerda S, Marwaha N, Yilmaz OH, Pinjic E, McAneny D, Lee SL, Drake FT. Noninvasive Follicular Thyroid Neoplasm with Papillary-Like Nuclear Features: Epidemiology and Long-Term Outcomes in a Strictly Defined Cohort. Thyroid. 2021; 31(1). DOI: https://doi.org/10.1089/thy.2019.0616.
Simon E, Vescovi A, Pescador MVB. Perfil epidemiológico dos pacientes com câncer de tireoide na cidade de Cascavel, Paraná, comparativamente ao restante do estado do Paraná entre 2009 a 2019. Revista Thêma Et Scientia. 2023;12(1):250-264. Disponível em: https://themaetscientia.fag.edu.br/index.php/rtes/article/view/1327.
Ferreira RLZ, Garcia ESGF. Incidência do câncer de tireoide em mulheres brasileiras. Repositório Unis. 2018. URI: http://repositorio.unis.edu.br/handle/prefix/326.
Denaro N, Romanò R, Alfieri S, Dolci A, Licitra L, Nuzzolese I, Ghidini M, Bareggi C, Bertaglia V, Solinas C, et al. The Tumor Microenvironment and the Estrogen Loop in Thyroid Cancer. Cancers. 2023; 15(9):2458. https://doi.org/10.3390/cancers15092458.
ROCHA, Ricardo Mai et al. Carcinoma bem diferenciado de tireoide: perfil epidemiológico, resultados cirúrgicos e resposta oncológica. Revista do Colégio Brasileiro de Cirurgiões. 2028;45(5)1-9. DOI: https://doi.org/10.1590/0100-6991e-20181934.
LeClair K, Bell KJL, Furuya-Kanamori L, Doi SA, Francis DO, Davies L. Evaluation of Gender Inequity in Thyroid Cancer Diagnosis Differences by Sex in US Thyroid Cancer Incidence Compared With a Meta-analysis of Subclinical Thyroid Cancer Rates at Autopsy. JAMA INTERNAL MEDICINE. 2021; 181(10): 1351-1358. DOI: https://doi.org/10.1001/jamainternmed.2021.4804.
Vaccarella S, Silvia Franceschi S, Bray F, Wild CP, Plummer M, Maso LD. Worldwide thyroid-cancer epidemic? The increasing impact of overdiagnosis. The New England Journal of Medicine. 2016;375:614-617. DOI: http://dx.doi.org/10.1056/NEJMp1604412.
Alonso‐Gordoa T, Jimenez‐Fonseca P, Martinez‐Trufero J, Navarro M, Porras I, Rubió‐Casadevall J, Valles MA, Basté N, Hernando J, Docampo LI. SEOM‐GETNE‐TTCC Clinical guideline thyroid cancer (2023). Clinical and Translational Oncology. 2024; 26:2902–2916. DOI: https://doi.org/10.1007/s12094-024-03736-6 .
West J, Wiemann BZ, Esce AR, Olson GT, Boyd NH. Thyroid Cancer Incidence and Tumor Size in New Mexico American Indians, Hispanics, and Non-Hispanic Whites, 1992 to 2019. Annals of Otology, Rhinology & Laryngology. 2024; 133(8).: 705-712. DOI: http://dx.doi.org/10.1177/00034894241256697.
Faro FN, Tupinambá Bertelli AAT, Scalissi NM, Cury AN, Padovani RP, Ferraz C. Active surveillance versus immediate surgery in the management of low-risk papillary thyroid microcarcinoma: comparison of long-term costs in Brazil. Arch Endocrinol Metab. 2024; 68(1-9): e230349.. DOI: http://dx.doi.org/10.20945/2359-4292-2023-0349.
Sanabria A, Ferraz C, Ku CHC, Padovani R, Palacios K, Paz JL, Roman A, Smulever A, Vaisman F, Pitoia F. Implementing active surveillance for low-risk thyroid carcinoma into clinical practice: collaborative recommendations for Latin America. Arch Endocrinol Metab. 2024; 68(1-12): e230371. DOI: http://dx.doi.org/10.20945/2359-4292-2023-0371.
Manfio PG, Chinelatto LAS, Hojaij FC. Active surveillance of papillary thyroid carcinoma in Latin America: a scoping review. Arch Endocrinol Metab. 2024; 68(1-6): e230495. DOI: http://dx.doi.org/10.20945/2359-4292-2023-0495.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2025 Revista Científica Integrada

This work is licensed under a Creative Commons Attribution 4.0 International License.











